FACULTY LIST
(alphabetical order)
Inhye E. Ahn, MD Lymphoid Malignancies Section, National Heart, Lung, and Blood Institute, Bethesda, United States
Othman Al-Sawaf, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
Iona Ashworth, PhD Department of Haematology, Brighton and Sussex University Hospital Trust, Brighton, United Kingdom
Francesc Bosch, MD, PhD Department of Haematology, University Hospital Vall d'Hebron, Autonomous University, Barcelona, Spain
Jennifer Brown, MD, PhD Department of Medical Oncology, Dana Farber Cancer Institute, Boston, United States
Chiara Cassarino, Laboratorio de Inmunología Oncológica, Instituto de Medicina Experimental (IMEX)-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)- Academia Nacional de Medicina (ANM), Buenos Aires, Argentina
Marta Coscia, MD, PhD Department of Hematology, University of Turin, Turin, Italy
Paula Cramer, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
Alexey V. Danilov, MD, PhD City of Hope National Medical Center, Duarte, United States
Matthew S. Davids, MD Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States
Thi Huong Lan Do, Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland
Barbara Eichhorst, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
Lesley Fallowfield, MD, Department of Oncology, University College London Medical School, London, United Kingdome
Kirsten Fischer, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
Paolo Ghia, MD University Vita-Salute San Raffaele, Milano, Italy
Romaine Guièze, MD CHU Clermont Ferrand, Clermont Ferrand, France
Michael Hallek, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
Paul J. Hampel, MD Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, United States
Carmen Herling, MD Clinic and Polyclinic for Hematology, Cell Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany
Henriette Huber, MD Karlsruhe Municipal Hospital, Karlsruhe, Germany
Nathalie Javidi-Sharifi, MD, PhD Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States
Arnon P. Kater, MD, PhD Lymphoma and Myeloma Center, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, Netherlands
Emma Kennedy, PhD Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Falmer, United Kingdom
Thomas J. Kipps, MD, PhD University of California, Department of Medicine, Moores Cancer Center, San Diego, California, United States
Binyamin A. Knisbacher, MD, PhD Cancer Research Center, Sheba Medical Center, Tel Hashomer, Israel
Viktoria Kohlhas, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
Nadine Kutsch, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
Stephen Martindale, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States
Kiyomi Mashima, MD, PhD Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States
Riccardo Moia, MD Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
Talha Munir, MD Department of Haematology, St. James's University Hospital, Leeds, United Kingdome
Ferran Nadeu, MD Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Sameer A. Parikh, MD Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, United States
Matthias Ritgen, MD Department of Medicine II, University of Schleswig-Holstein, Kiel, Germany
Pauline Robbe, PhD Department of Molecular Haematology, Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, United Kingdome
Ilaria Romano, MD, PhD Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
Richard Rosenquist Brandell, MD, PhD Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Davide Rossi, MD, PhD Hospital San Giovanni, Bellinzona, Switzerland
Neil Ruthen, Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, United States
Lydia Scarfó, MD Strategic Research Program on Chronic Lymphocytic Leukemia, IRCCS Ospedale San Raffaele, Milano, Italy; Università Vita Salute San Raffaele, Milano, Italy
Florian Simon, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
Philipp B. Staber, MD, PhD Department of Hematology and Hemostosiology, University Hospital Vienna, Austria
Deborah M. Stephens, MD Internal Medicine/Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, United States
Stefan Stilgenbauer, MD Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
Eugen Tausch, MD Division of CLL, Department of Internal Medicine III, University of Ulm, Ulm, Germany
Philip A. Thompson, MD, Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia
Patrick D. Thornton, MD Department of Haematology, Beaumont Hospital, Dublin, Ireland
Martin Trepel, MD Department of Hematology and Medical Oncology, Augsburg University Hospital, Augsburg, Germany
Julia von Tresckow, MD Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Clemens M. Wendtner, MD Hematology and Internal Oncology, Interdisciplinary Oncology Center (IOZ), Munich, Germany
Alexander F. Vom Stein, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
Jennifer A. Woyach, MD The Ohio State University Comprehensive Cancer Center, Columbus, Columbus, United States
Loic Ysebeart, MD, PhD Institut Universitaire du Cancer-Toulouse Oncopole, Haematology Department, Toulouse, France